Zealand Pharma A-S Aktie [WKN DE: A0YJW7 / ISIN: DK0060257814]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Zealand Pharma A-S

29.12.23		Total number of shares and voting rights in Zealand Pharma at December 29, 2023 (GlobeNewswire)
23.12.23		U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing (GlobeNewswire)
07.12.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
07.12.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
04.12.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
30.11.23		Total number of shares and voting rights in Zealand Pharma at November 30, 2023 (GlobeNewswire)
30.11.23		Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers (GlobeNewswire)
16.11.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
09.11.23		Zealand Pharma Announces Financial Results for the First Nine Months of 2023 (GlobeNewswire)
20.10.23		Zealand Pharma major shareholder announcement: Polar Capital (GlobeNewswire)
29.09.23		Total number of shares and voting rights in Zealand Pharma at September 29, 2023 (GlobeNewswire)
14.09.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
14.09.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
31.08.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
31.08.23		Total number of shares and voting rights in Zealand Pharma at August 31, 2023 (GlobeNewswire)
30.08.23		Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism (GlobeNewswire)
25.08.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
24.08.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
17.08.23		Zealand Pharma Announces Financial Results for the First Half of 2023 (GlobeNewswire)
03.07.23		Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 (GlobeNewswire)
30.06.23		Total number of shares and voting rights in Zealand Pharma at June 30, 2023 (GlobeNewswire)
08.06.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
31.05.23		Total number of shares and voting rights in Zealand Pharma at May 31, 2023 (GlobeNewswire)
25.05.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
23.05.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
12.05.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
11.05.23		Zealand Pharma Announces Financial Results for the First Quarter of 2023 (GlobeNewswire)
10.05.23		Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight (GlobeNewswire)
28.04.23		Total number of shares and voting rights in Zealand Pharma at April 28, 2023 (GlobeNewswire)
25.04.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
19.04.23		Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 (GlobeNewswire)
04.04.23		Zealand Pharma completes registration of capital increase (GlobeNewswire)
03.04.23		Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen (GlobeNewswire)
31.03.23		Total number of shares and voting rights in Zealand Pharma at March 31, 2023 (GlobeNewswire)
30.03.23		Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion (GlobeNewswire)
30.03.23		Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares (GlobeNewswire)
28.03.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
28.03.23		Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 (GlobeNewswire)
13.03.23		Zealand Pharma Provides Update on Silicon Valley Bank Closure (GlobeNewswire)
12.03.23		Zealand Pharma Provides Statement on Silicon Valley Bank Closure (GlobeNewswire)
10.03.23		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
09.03.23		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
02.03.23		Zealand Pharma convenes its Annual General Meeting 2023 (GlobeNewswire)
02.03.23		Zealand Pharma Announces Full Year Results for 2022 (GlobeNewswire)
17.11.22		Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants (GlobeNewswire)
17.11.22		Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons (GlobeNewswire)
08.11.22		Zealand Pharma to Participate in Upcoming Investor Conferences (GlobeNewswire)
03.11.22		Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 (GlobeNewswire)
31.10.22		Total number of shares and voting rights in Zealand Pharma at October 31, 2022 (GlobeNewswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Bitcoin bald bei 100.000 Dollar? MicroStrategy-CEO zeigt sich bullish - 100k-Party schon geplant

Pierer Mobility-Aktie zweistellig im Plus: Pierer dementiert Mateschitz-Einstieg bei KTM

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

UN-Klimagipfel in Baku: Baerbock warnt vor 'Killerstürmen'

NEL ASA-Aktie fällt immer tiefer: Analysten sehen Risiken und raten zum Verkauf

Angespannte Stimmung in Frankfurt: LUS-DAX gibt am Nachmittag nach

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	24.11.2024 16:57
Kaufwert:	EUR
	Hinzufügen Speichern